AI-Augmented Advances in the Diagnostic Approaches to Endometrial Cancer.

IF 4.5 2区 医学 Q1 ONCOLOGY
Cancers Pub Date : 2025-05-28 DOI:10.3390/cancers17111810
Nabiha Midhat Ansari, Usman Khalid, Daniel Markov, Kristian Bechev, Vladimir Aleksiev, Galabin Markov, Elena Poryazova
{"title":"AI-Augmented Advances in the Diagnostic Approaches to Endometrial Cancer.","authors":"Nabiha Midhat Ansari, Usman Khalid, Daniel Markov, Kristian Bechev, Vladimir Aleksiev, Galabin Markov, Elena Poryazova","doi":"10.3390/cancers17111810","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with diagnostic accuracy and early detection being critical to patient outcomes. Recent advances in artificial intelligence (AI) offer new opportunities to enhance diagnostic precision and clinical decision-making.</p><p><strong>Objectives: </strong>This literature review aims to explore recent developments in AI-augmented diagnostic approaches for EC, with a focus on applications in histopathology, imaging, and multi-omics, and to assess their clinical impact and future potential.</p><p><strong>Methods: </strong>A non-systematic literature review was conducted to examine recent advances in artificial intelligence applications for the diagnosis of EC. Relevant studies were identified through searches on PubMed and Google Scholar, focusing on the integration of AI techniques in histopathology, imaging, and multi-omics data.</p><p><strong>Conclusions: </strong>AI-driven diagnostic tools have shown high performance in detecting and characterizing EC across multiple modalities, often matching or exceeding expert-level accuracy. These technologies hold promise for earlier detection, better risk assessment, and more personalized treatment planning. However, further research and validation are needed to address current limitations and support their broader integration into clinical workflows.</p>","PeriodicalId":9681,"journal":{"name":"Cancers","volume":"17 11","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153548/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/cancers17111810","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with diagnostic accuracy and early detection being critical to patient outcomes. Recent advances in artificial intelligence (AI) offer new opportunities to enhance diagnostic precision and clinical decision-making.

Objectives: This literature review aims to explore recent developments in AI-augmented diagnostic approaches for EC, with a focus on applications in histopathology, imaging, and multi-omics, and to assess their clinical impact and future potential.

Methods: A non-systematic literature review was conducted to examine recent advances in artificial intelligence applications for the diagnosis of EC. Relevant studies were identified through searches on PubMed and Google Scholar, focusing on the integration of AI techniques in histopathology, imaging, and multi-omics data.

Conclusions: AI-driven diagnostic tools have shown high performance in detecting and characterizing EC across multiple modalities, often matching or exceeding expert-level accuracy. These technologies hold promise for earlier detection, better risk assessment, and more personalized treatment planning. However, further research and validation are needed to address current limitations and support their broader integration into clinical workflows.

人工智能增强子宫内膜癌诊断方法的进展。
背景:子宫内膜癌(EC)是发达国家最常见的妇科恶性肿瘤,诊断的准确性和早期发现对患者的预后至关重要。人工智能(AI)的最新进展为提高诊断精度和临床决策提供了新的机会。目的:本文献综述旨在探讨人工智能增强EC诊断方法的最新进展,重点关注其在组织病理学、影像学和多组学方面的应用,并评估其临床影响和未来潜力。方法:通过非系统文献综述,探讨人工智能在诊断EC方面的最新进展。通过检索PubMed和谷歌Scholar,发现相关研究,重点关注AI技术在组织病理学、影像学和多组学数据中的整合。结论:人工智能驱动的诊断工具在跨多种模式检测和表征EC方面表现出高性能,通常达到或超过专家水平的准确性。这些技术有望实现更早的检测、更好的风险评估和更个性化的治疗计划。然而,需要进一步的研究和验证来解决当前的局限性,并支持它们更广泛地整合到临床工作流程中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancers
Cancers Medicine-Oncology
CiteScore
8.00
自引率
9.60%
发文量
5371
审稿时长
18.07 days
期刊介绍: Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信